Anti-E. coli TolC Recombinant Antibody scFv Fragment (MRO-008MZ-S(P))

CAT#: MRO-008MZ-S(P)

This antibody against TolC fragment improves the sensitivity of bacteria to antibiotics and can specifically and effectively inhibit the function of medicament resistant outer membrane protein TolC of Escherichia coli so as to solve the problem of bacterial medicament resistance.

Specifications

  • Host Species
  • Rabbit
  • Type
  • Rabbit mAb
  • Specificity
  • Escherichia coli
  • Applications
  • WB
  • Related Disease
  • Bacterial medicament resistance

Target

  • Alternative Names
  • colE1-i; ECK3026; JW5503; mtcB; mukA; refI; toc; weeA
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for MRO-008MZ-S(P). Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Great for Western Blots
The antibody provided clear bands in Western blotting. It was very effective in detecting TolC protein in our samples, even with minimal sample preparation.
Breast cancer biomarkers at key points during disease progression
Works Well with Secondary Antibodies
The compatibility with anti-His-tag secondary antibodies made it easy to integrate into our existing detection systems.
Breast cancer biomarkers at key points during disease progression
Strong Binding Affinity
The strong and specific binding affinity of this scFv fragment to TolC protein was evident in our various assays. Provided great results!

Q&As

  1. What is the host organism for the Anti-E. coli TolC Recombinant Antibody scFv Fragment (MRO-008MZ-S(P))?

    A: In order to produce the polyclonal response, rabbits immunized with E. coli K99 pili are used to produce the scFv fragment antibody.

  2. What is the significance of the scFv format?

    A: For customized applications, the single-chain variable fragment (scFv) format guarantees monovalency, decreased immunogenicity, and simplicity of genetic modification.

  3. How is the identity of the antibody confirmed?

    A: By means of sequencing, binding specificity tests, and functional validation in relevant assays, the identity of the scFv fragment is verified.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "tolC"

Select a product category from the dropdown menu below to view related products.

Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare